{"id":"W2331189781","doi":"10.1016/j.juro.2016.03.174","title":"Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy","year":2016,"lang":"en","type":"article","venue":"The Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Humber River Regional Hospital; University of Toronto","funders":"Astellas Pharma","keywords":"Solifenacin; Medicine; Mirabegron; Overactive bladder; Urology; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006954594,0.0004891551,0.001720428,0.0003684616,0.000216106,0.0004317792,0.0003983152,0.0005435103,0.002092802],"category_scores_gemma":[0.0009429326,0.00030433,0.0008612523,0.0002425053,0.0004296598,0.0003456659,0.0002343625,0.0009636924,0.0002333467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004444859,"about_ca_system_score_gemma":0.0004328907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000391439,"about_ca_topic_score_gemma":0.001712281,"domain_scores_codex":[0.9995858,0.0002102308,0.00004430924,0.00004752999,0.00005801667,0.00005407237],"domain_scores_gemma":[0.9995402,0.00017536,0.0001116074,0.00002172611,0.00001963421,0.0001314151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7784592,0.01640541,0.01661803,0.001652039,0.002300775,0.0005520322,0.0002430063,0.001246481,0.02442708,0.0001334281,0.0006984277,0.1572641],"study_design_scores_gemma":[0.3371566,0.604466,0.04728744,0.000176551,0.001912717,0.0008266707,0.0001695405,0.001634443,0.003895535,0.0001156657,0.002310672,0.00004825173],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950997,0.00391009,0.00007683551,0.0001707202,0.0000785735,0.0001512282,0.00005180035,0.00001533513,0.0004457416],"genre_scores_gemma":[0.9976097,0.001241363,0.0003254019,0.0001898493,0.0001083671,0.0001368906,0.0001011205,0.000002178063,0.0002850883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002092802,"threshold_uncertainty_score":0.007001162,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0155137561460734,"score_gpt":0.3179390451930831,"score_spread":0.3024252890470097,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}